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Abstract Chitinases are ubiquitous chitin-fragmenting hydro-
lases. They are synthesized by a vast array of organisms,
including those not composed of chitin. Here, we describe a novel
serum chitinase (chitin-binding protein b04, CBPb04), which is
expressed in bovine liver. Although CBPb04 is secreted as an
endocrine chitinase, it shows higher homology with human
gastrointestinal tract exocrine chitinase (AMCase) than with
macrophage endocrine chitinase (human chitotriosidase). This
suggests that cows have a specific defense against chitin-
containing microorganisms. CBPb04 mRNA is expressed in
hepatocytes. This is the first report of a hepatogenic mammalian
chitinase. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The immune response to microbial pathogens relies on both
innate and adaptive components. The immediate, innate re-
sponse is mediated largely by white blood cells, such as neu-
trophils and macrophages, cells that phagocytose and kill
pathogens. Most pathogen cell-wall constituents, such as lipo-
polysaccharide, glucan, mannans, mannoproteins, and chitin,
are recognized as foreign substances by endogenous pathogen
recognition systems. Chitin is found in insects, crustaceans,
and most fungi, but not in plants, vertebrates, or prokaryotes.
One role of chitin, demonstrated recently in Blastomyces der-
matitidis, is in anchoring and displaying a surface adhesin and
virulence determinant [1]. Chitinases, however, are synthesized
by a vast array of organisms, including organisms that do not
produce chitin. The proposed role of plant chitinase is as a
defense mechanism against chitin-containing organisms. Puri-
¢ed barley chitinase inhibits the growth of fungal hypha [2].
In mammals, human serum contains a chitinase, called chito-
triosidase, and its mRNA is expressed in macrophages [3,4]. It
has been proposed that human chitotriosidase plays a role in
host defense responses similar to that of plant chitinases. Hu-
man chitotriosidase is the only mammalian endocrine secreted
chitinase that has been identi¢ed and cloned. There have been
many studies of human chitotriosidase, but few of other mam-
malian endocrine chitinases. In this study, we identi¢ed and
puri¢ed a novel bovine serum chitinase, which is expressed in
bovine liver. We also cloned the cDNA encoding the enzy-
matically active chitinase.
2. Materials and methods
2.1. Bovine serum
Bovine serum was prepared from the blood of a healthy Holstein
cow. The serum was stored at 320‡C before use.
2.2. Puri¢cation of CBPb04
To isolate bovine serum chitinase, called CBPb04, 3.5 l of bovine
serum was applied to a chitin column (4U27 cm, chitin powder from
crab shells, Nacalai Tesque). The column was washed at 1 ml/min
with phosphate-bu¡ered saline (PBS), and with 0.1 M EDTA and
0.1 M N-acetyl-D-glucosamine (GlcNAc, Nacalai Tesque), for elimi-
nating C-type lectins and GlcNAc sensitive proteins, respectively, and
then eluted with 500 ml of 0.1 M acetic acid at the same £ow. The
eluted peak was dialyzed against a saturated ammonium sulfate solu-
tion, and the resultant precipitate was collected by centrifugation at
10 000Ug and 4‡C for 30 min. The pellet was dissolved into the
minimum volume of 100 mM Tris^HCl (pH 7.5). The clear super-
natant was applied on a column of Superdex 200 (Amersham Phar-
macia Biotech, Piscataway, NY, USA) equilibrated with 100 mM
Tris^HCl (pH 7.5). The eluted fractions were analyzed by sodium
dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE).
The peak fractions were further puri¢ed with DEAE-TY650M (TO-
SOH). Unless speci¢ed otherwise, the protein concentrations were
determined by UV measurement. The protein solutions were stored
at 320‡C until use.
2.3. Enzyme assay
Overall chitinase activity was determined using chitin azure as a
substrate, suspended in McIlvaine bu¡er (100 mM citric acid, 200
mM sodium phosphate) at the indicated pH, as previously reported
[5].
2.4. Amino acid sequence analysis and peptide mapping
The N-terminal sequence of puri¢ed CBPb04 was determined by
automated Edman degradation using a PPSQ-21 protein sequencer
(Shimadzu). To obtain internal peptides, the proteins were digested
in gels by lysyl-end peptidase, extracted, and puri¢ed by reverse-phase
chromatography using a WRPC C2/C18 column (Amersham Pharma-
cia Biotech). The sequences obtained were compared with those in the
DDBJ. Peptide mapping was performed according to Goumon et al.
[6]. The puri¢ed peptides were analyzed by matrix-assisted laser de-
sorption ionization time-of-£ight (MALDI-TOF) (PerSeptive Biosys-
tems).
0014-5793 / 01 / $20.00 ß 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 2 8 9 3 - 9
*Corresponding author. Fax: (81)-19-621 6212.
E-mail address: shuto@iwate-u.ac.jp (B. Syuto).
1 The nucleotide sequence reported in this paper has been submitted
to the DDBJ Nucleotide Sequence Database with accession number
AB051629.
Abbreviations: SDS^PAGE, sodium dodecyl sulfate^polyacrylamide
gel electrophoresis; PCR, polymerase chain reaction; RACE, rapid
ampli¢cation of cDNA ends
FEBS 25290 28-9-01
FEBS 25290 FEBS Letters 506 (2001) 127^130
2.5. Cloning of CBPb04
Total liver RNA was isolated from a Japanese Black bull using
Trizol reagent (Gibco BRL, Grand Island, NY, USA). First strand
cDNA synthesis was performed on 8 Wg of total RNA using Super-
Script1 II RNase H3 reverse transcriptase (Gibco BRL) and a dT18-
tailed oligonucleotide primer. The ¢rst strand cDNA was used as the
template for polymerase chain reaction (PCR) ampli¢cation with Taq
DNA polymerase (Promega Co., Madison, WI, USA), and forward
and reverse primers derived from an internal amino acid sequence.
After PCR, the DNA fragment was puri¢ed, and subcloned into the
pGEM-T easy vector (Promega Co.). DNA sequence analysis was
performed using the Big Dye terminator method (PE Applied Biosys-
tems). In order to amplify the missing 5P and 3P sequences, we per-
formed 5P- and 3P-rapid ampli¢cation of the cDNA ends (RACE)
using RACE kits from Gibco BRL.
2.6. Northern blot analysis
Total RNA was separated in 1% agarose/formaldehyde gels, and
transferred to nylon membranes (Amersham Pharmacia Biotech),
which were hybridized with [K32P]dCTP-labeled CBPb04 probe (posi-
tion 503^960) and exposed to X-ray ¢lm (Kodak).
2.7. RT-PCR
To con¢rm the distribution of CBPb04 cDNA, an reverse transcrip-
tase (RT)-PCR experiment was performed using Taq DNA polymer-
ase and ¢rst strand cDNA as the template. The reaction was done
using a CBPb04 cDNA-speci¢c primer set.
2.8. Transient expression in 293T cells
The cDNA encoding CBPb04 was subcloned into the eukaryotic
expression vector pCAGGS/MCS [7]. 293T cells were cultured in
Dulbecco’s modi¢ed Eagle’s medium with 10% fetal calf serum
(FCS). FuGENE1 6 Transfection Reagent (Roche) was used for
the transfection experiments following the manufacturer’s instruc-
tions. Recombinant CBPb04 in the medium was separated by a⁄nity
chromatography using a chitin column as described in Section 2.2.
2.9. In situ hybridization
In situ hybridization was performed as previously described [8].
Two non-overlapping antisense oligonucleotides, which are comple-
mentary to nucleotide residues 771^805 and 1074^1118 of the bovine
CBPb04 cDNA, were used for in situ hybridization. These oligonu-
cleotides were labeled with [35S]dATP, using terminal deoxyribonu-
cleotidyl transferase (Promega Co.). The cryostat sections were ¢xed,
acetylated, and hybridized with the 35S-labeled probes. Then, the sec-
tions were either exposed to Kodak BioMax MR for 1 week, or
dipped in Kodak NTB2 nuclear track emulsion and exposed for
1 month.
3. Results and discussion
Chitin-binding protein was puri¢ed by a⁄nity chromatog-
raphy with a chitin column (Fig. 1A). One fraction eluted
from chitin with 0.1 M acetic acid contained IgM, IgG, albu-
min, a 50-kDa protein, and a 20-kDa protein. This fraction
was concentrated by dialysis against a saturated ammonium
sulfate solution overnight and subjected to Superdex 200 gel
Fig. 1. Puri¢cation of CBPb04 and chitinase activity assay of the
puri¢ed CBPb04. A: A⁄nity chromatogram. B: SDS^PAGE analy-
sis of puri¢ed CBPb04. M, molecular weight standards; CBP, puri-
¢ed CBPb04. C: Chitinase activity assay of puri¢ed CBPb04.
Fig. 2. Deduced amino acid sequence of CBPb04. The hydrophobic
leader peptide (amino acids 1^21) is underlined with a single line.
The putative chitin-binding domain (amino acids 425^473) is under-
lined with a double line. The N-linked glycosylation site is under-
lined with dots. The peptide sequences determined by the Edman
method are boxed.
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¢ltration. The fraction containing the V50-kDa protein was
further puri¢ed by anion exchange chromatography with a
DEAE-TY650M column. CBPb04 was contained in a pass-
through fraction, and appeared as three bands with a molec-
ular mass of V50 kDa (Fig. 1B). These proteins were identi-
¢ed as isoforms of the CBPb04 molecule by peptide mapping
of lysyl-end peptidase digestion products (data not shown).
The amino acid sequence of one internal peptide showed
that CBPb04 possesses the highly conserved sequence of fam-
ily 18 glycosyl hydrolases, which are also chitinases. There-
fore, we investigated whether CBPb04 has chitinolytic activity.
Chitinolytic activity was assayed using chitin azure as a sub-
strate. CBPb04 showed chitinolytic activity, which was opti-
mal at a pH between 5.6 and 7.6 (Fig. 1C). Therefore,
CBPb04 is a bovine serum chitinase. Lundblad et al. [9] re-
ported bovine serum chitinase activity in 1979, but there have
been no reports in the literature since then. Their puri¢cation
methods were very di¡erent from ours, so we cannot deter-
mine whether their chitinase was identical to CBPb04. More-
over, it is uncertain whether their chitinase was a chitotriosi-
dase, because they did not report its primary structure.
To clarify the relationship between CBPb04 and human
chitotriosidase, we obtained the cDNA sequence of CBPb04
from a combination of PCR products as described in Section
2. The nucleotide sequence of the cloned cDNA contained an
open reading frame 1419 bp long, and the open reading frame
encoded a protein with a characteristic N-terminal 21 amino
acid endoplasmic reticulum signal peptide, immediately fol-
lowed by the N-terminal sequence established for puri¢ed
CBPb04. After removing the signal sequence, the cDNA en-
coded a predicted mature protein, 472 amino acids long (Fig.
2), with a calculated molecular weight of 49 954 and a pI of
5.26 (ExPASy Compute pI/Mw tool, Swiss Institute).
Overall sequence comparison of CBPb04 with human chi-
totriosidase showed 60.7% identity for the cDNA, and 51.4%
identity for the deduced amino acids. Like human chitotrio-
sidase, CBPb04 was predicted to contain an N-terminal cata-
lytic domain of about 39 kDa, a hinge region, and a C-termi-
nal chitin-binding domain. Analysis of the catalytic domain of
bacterial chitinase was characterized by site-directed mutagen-
esis experiments in Bacillus circulans [10,11]. This revealed the
importance of the 197Asp, 200Asp, 202Asp, and 204Glu residues
Fig. 3. The tissue distribution of CBPb04 mRNA. A: Northern blot analysis. 10 Wg of total RNA was separated on an agarose gel as described
in Section 2. The positions of the 28S and 18S rRNA bands are indicated with arrows. As a control for RNA loading, a glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) probe was used (data not shown). Lane 1, brain; lane 2, heart; lane 3, lung; lane 4, liver; lane 5, kidney;
lane 6, spleen; lane 7, small intestine; lane 8, colon; lane 9, lymph node; lane 10, agmen peyerianum. B: RT-PCR. A CBPb04 cDNA-speci¢c
primer set was used to detect CBPb04 cDNA. As a control, a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA-speci¢c primer set
was used. C: In situ hybridization for CBPb04 mRNA expression in the bovine liver (left and center panels) and mandibular gland (right pan-
el). Hybridized sections were exposed to X-ray ¢lms. Intense signals, appearing as bright image, are found only in the liver. Bar = 5 mm. D: In
situ hybridization (micro-autoradiography) showing CBPb04 mRNA expression in the liver. The signals are localized in all the hepatocytes, but
not interlobular connective tissue (c) including blood vessels. Bar = 20 Wm.
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in the catalytic events of bacterial chitinase A1. This domain
is also conserved in human chitotriosidase, but not in several
mammalian chitinase-like proteins, which have no chitinase
activity [12]. This domain is conserved in CBPb04, and ex-
pression of the cloned cDNA in 293T cells led to the secretion
of an active chitinase (data not shown). This domain may also
be essential for the chitinase activity of CBPb04. Tjoelker et
al. reported that the C-terminal 49 amino acids of human
chitotriosidase are necessary and su⁄cient for binding to chi-
tin. Furthermore, they reported that mutation of 420Cys, or
any of the ¢ve cysteines within the binding domain, to serine
renders it inactive [13]. CBPb04 also conserved all of these
cysteines. CBPb04 might bind to chitin by this C-terminal
domain, as does human chitotriosidase.
In spite of the similarities between CBPb04 and human
chitotriosidase, it is inappropriate to consider CBPb04 as a
bovine chitotriosidase. Screening the GenBank database using
CBPb04 cDNA revealed high homology with TSA1902 (Gen-
Bank accession numbers AB025008 and AB025009) from a
human lung cDNA library [14]. Independent of our study,
Boot et al. recently reported a mammalian chitinase, AM-
Case, in the gastrointestinal tract ; human AMCase (GenBank
accession number AF290004) is almost identical to TSA1902
[15]. Sequence comparison of CBPb04 with human TSA1902/
AMCase revealed 83.7% identity, which is much higher than
that between CBPb04 and chitotriosidase (60.7%). Although
the CBPb04 cDNA sequence showed high homology with
TSA1902/AMCase, we observed CBPb04 mRNA expression
only in the liver, and not in the abomasum, proventriculus
(rumen, reticulum and omasum), or lung, where TSA1902/
AMCase is expressed abundantly (Fig. 3A,B).
To our knowledge, human chitotriosidase is the only mam-
malian endocrine chitinase that has been cloned and charac-
terized in detail. In our studies, however, chitotriosidase was
not found in bovine serum and its cDNA was not detected in
the spleen, where human chitotriosidase is abundantly ex-
pressed (data not shown). In situ hybridization analysis using
two non-overlapping anti-sense oligonucleotide probes
showed consistent labeling in all tissues examined. Intense
signals for CBPb04 mRNA were found only in the liver,
and not in the salivary glands, stomach, intestine, lung, or
spleen (Fig. 3C). In the liver, CBPb04 mRNA expression
was localized to essentially all hepatocytes (Fig. 3D). From
a developmental perspective, since hepatocytes are derived
from the primitive gut epithelium, CBPb04 might be more
closely related to TSA1902/AMCase than to human chitotrio-
sidase. In evolutionary terms, these results suggest that cows
might have selected for secreting CBPb04 as an endocrine
chitinase rather than as an exocrine chitinase, like AMCase.
Since cows have abundant chitinolytic activity derived from
lysozymes or chitinolytic microorganisms in the abomasum
and rumen [16^18], a chitinase of host origin may not be
required in the gastrointestinal tract.
It was recently reported that a recessively inherited de¢-
ciency in chitotriosidase is common [19^20]. About one of
20 individuals is completely de¢cient in enzymatically active
chitotriosidase, and the prevalence of the de¢ciency suggests
that chitotriosidase no longer ful¢lls an important defense
function under normal circumstances. Therefore, it is possible
that cows do not need chitotriosidase in serum. Alternatively,
the serum chitinolytic activity of CBPb04 in cows may be
su⁄cient for some innate immuno-response, such as protec-
tion against chitin-containing microorganisms. The ability to
secrete CBPb04 as an endocrine chitinase might be an advan-
tage in innate immunity, similar to that of plant chitinase.
These ¢ndings suggest that studying endocrine and exocrine
chitinases in cows and humans might be a key to character-
izing the function of mammalian chitinases, which do not
have a substrate in the mammal body.
In conclusion, we reported a novel serum chitinase that is
expressed in bovine hepatocytes. This is the ¢rst report of a
mammalian chitinase that is expressed in the liver. Although
CBPb04 showed high homology with gastrointestinal tract
exocrine secreted chitinase, CBPb04 was expressed only in
the liver, and was secreted as an endocrine chitinase. These
¢ndings suggest that cows have a speci¢c defense against chi-
tin-containing microorganisms.
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